Dear Readers,

welcome to the this year's first issue of “OncoReview”.

Prostate cancer is still the most common malignancy among men and one of the most common mortality factors in this population of patients. In the presented series of articles, oncologists from leading Polish oncology centers present the possibilities of treating this cancer with the use of moder  androgen receptor inhibitor – apalutamide.

On the other hand, Kade et al., in their case study, reminded about multiple myeloma, which can be the cause of bone pains often encountered in the practice of a family doctor. I hope you enjoy this new issue of our magazine. Thank you for reading it.

EDITOR-IN-CHIEF (Europe)
Radosław Grabysa, MD, PhD, Associate Professor